Land: Sør-Afrika
Språk: engelsk
Kilde: South African Health Products Regulatory Authority (SAHPRA)
Sad-otc
DIMETAPP® EXTENTABS SCHEDULING STATUS: S2 PROPRIETARY NAME (and dosage form): DIMETAPP ® EXTENTABS COMPOSITION: Each long acting tablet contains: Brompheniramine Maleate 12,00 mg Phenylephrine Hydrochloride 15,00 mg Phenylpropanolamine Hydrochloride 15,00 mg PHARMACOLOGICAL CLASSIFICATION: A 5.8 Preparations for the common cold including nasal decongestants and antihistamines. PHARMACOLOGICAL ACTION: The combination has antihistaminic and sympathomimetic properties. INDICATIONS: For the symptomatic relief of colds and flu. DIMETAPP EXTENTABS are specially formulated to release their ingredients in a uniform and continuous manner, thus providing relief of symptoms for 8 to 10 hours. CONTRA-INDICATIONS: Hypersensitivity to the active ingredients. Coma or pre-coma states. Known brain damage or epilepsy. It should not be given to patients being treated with mono-amine oxidase inhibitors or within 10 days of stopping such treatment. Phenylephrine is contra-indicated in severe coronary disease, hypertension or cardio-vascular disease, hyperthyroidism and in pregnant patients, where it may cause foetal hypoxia. Phenylpropanolamine, in addition to the above, should not be given in diabetes mellitus. DOSAGE AND DIRECTIONS FOR USE: Take one DIMETAPP EXTENTAB tablet in the morning and at night. WARNINGS: This medicine may lead to drowsiness and impaired concentration, which is aggravated by the simultaneous intake of alcohol or other central nervous system depressant agents. Patients should be warned not to drive a motor vehicle or operate dangerous machinery or climb dangerous heights, as impaired decision making could lead to accidents. SIDE EFFECTS AND SPECIAL PRECAUTIONS: The most common side-effect from administration Les hele dokumentet